US Stock MarketDetailed Quotes

ZVSA ZyVersa Therapeutics

Watchlist
  • 1.4000
  • -0.1200-7.89%
Close Nov 8 16:00 ET
  • 1.4400
  • +0.0400+2.86%
Post 16:49 ET
1.50MMarket Cap-53P/E (TTM)

ZyVersa Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 12, 2022
(Q4)Dec 12, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-46.52%2.75M
-38.45%2.83M
10.82%14.42M
-59.32%1.78M
-14.51%2.9M
173.43%5.15M
36.33%4.59M
68.90%13.01M
145.76%4.37M
60.57%3.4M
Selling and administrative expenses
-47.96%2.04M
-34.57%2.31M
47.44%11.21M
-50.66%1.52M
110.05%2.23M
237.56%3.93M
53.65%3.54M
36.29%7.61M
169.45%3.08M
-37.86%1.06M
-General and administrative expense
-47.96%2.04M
-34.57%2.31M
47.44%11.21M
-50.66%1.52M
110.05%2.23M
237.56%3.93M
53.65%3.54M
36.29%7.61M
169.45%3.08M
-37.86%1.06M
Research and development costs
-41.91%709.05K
-51.42%512.94K
-40.69%3.21M
-80.03%257.11K
-71.13%673.94K
69.67%1.22M
-1.03%1.06M
154.57%5.41M
103.07%1.29M
473.57%2.33M
Operating profit
46.52%-2.75M
38.45%-2.83M
-10.82%-14.42M
59.32%-1.78M
14.51%-2.9M
-173.43%-5.15M
-36.33%-4.59M
-68.90%-13.01M
-145.76%-4.37M
-60.57%-3.4M
Net non-operating interest income expense
81.53%-58
-109.37%-101
100.11%457
99.80%-98
99.70%-210
99.78%-314
100.64%1.08K
47.95%-427.54K
75.71%-49.72K
69.24%-69.35K
Non-operating interest income
----
----
--457
---98
----
----
--1.08K
----
----
----
Non-operating interest expense
----
--101
----
----
-99.70%210
----
----
-47.95%427.54K
-75.71%49.72K
-69.24%69.35K
Total other finance cost
-81.53%58
----
----
----
----
-99.78%314
----
----
----
----
Other net income (expense)
-15,276.16%-93.33M
-6,422.63%-12.16M
-414,259.20%-81.18M
-237.46%-607K
-1,627.88%-186.4K
-149.59%-228.1K
Gain on sale of security
----
----
----
----
----
----
----
-366.11%-607K
-1,627.88%-186.4K
-192.53%-228.1K
Special income (charges)
--0
----
---93.33M
---12.16M
--0
---81.18M
----
--0
--0
--0
-Less:Impairment of capital assets
--0
----
--11.9M
--0
--0
--11.9M
----
--0
--0
--0
-Write off
--0
----
--81.44M
--12.16M
--0
--69.28M
----
--0
--0
--0
Income before tax
96.81%-2.75M
38.43%-2.83M
-667.06%-107.75M
-202.78%-13.93M
21.39%-2.9M
-4,207.19%-86.33M
-22.48%-4.59M
-73.77%-14.05M
-133.72%-4.6M
-96.43%-3.69M
Income tax
100.12%9.71K
0
-9.46M
-596.07K
-485
-7.81M
-1.05M
0
0
0
Net income
96.48%-2.76M
20.24%-2.83M
-599.75%-98.3M
-189.82%-13.34M
21.40%-2.9M
-3,817.40%-78.51M
5.46%-3.54M
-73.77%-14.05M
-133.72%-4.6M
-96.43%-3.69M
Net income continuous Operations
96.48%-2.76M
20.24%-2.83M
-599.75%-98.3M
-189.82%-13.34M
21.40%-2.9M
-3,817.40%-78.51M
5.46%-3.54M
-73.77%-14.05M
-133.72%-4.6M
-96.43%-3.69M
Minority interest income
Net income attributable to the parent company
96.48%-2.76M
20.24%-2.83M
-599.75%-98.3M
-189.82%-13.34M
21.40%-2.9M
-3,817.40%-78.51M
5.46%-3.54M
-73.77%-14.05M
-133.72%-4.6M
-96.43%-3.69M
Preferred stock dividends
-20.64%7.95M
0
-99.67%32.37K
2,290.05%7.92M
10.02M
0
9.68M
Other preferred stock dividends
Net income attributable to common stockholders
96.80%-2.76M
20.24%-2.83M
-341.53%-106.25M
-189.82%-13.34M
78.06%-2.93M
-3,600.80%-86.43M
5.46%-3.54M
-197.66%-24.06M
-133.72%-4.6M
-611.59%-13.38M
Basic earnings per share
98.05%-33.1
96.67%-45.3
-214.85%-1.09K
81.44%-32.9179
93.89%-31.5
-4,740.34%-1.69K
-2,408.63%-1.36K
-147.42%-346.104
-523.36%-177.3656
-1,797.86%-515.5409
Diluted earnings per share
98.05%-33.1
96.67%-45.3
-214.85%-1.09K
81.44%-32.9179
93.89%-31.5
-4,740.34%-1.69K
-2,408.63%-1.36K
-147.42%-346.104
-523.36%-177.3656
-1,797.86%-515.5409
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 12, 2022(Q4)Dec 12, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -46.52%2.75M-38.45%2.83M10.82%14.42M-59.32%1.78M-14.51%2.9M173.43%5.15M36.33%4.59M68.90%13.01M145.76%4.37M60.57%3.4M
Selling and administrative expenses -47.96%2.04M-34.57%2.31M47.44%11.21M-50.66%1.52M110.05%2.23M237.56%3.93M53.65%3.54M36.29%7.61M169.45%3.08M-37.86%1.06M
-General and administrative expense -47.96%2.04M-34.57%2.31M47.44%11.21M-50.66%1.52M110.05%2.23M237.56%3.93M53.65%3.54M36.29%7.61M169.45%3.08M-37.86%1.06M
Research and development costs -41.91%709.05K-51.42%512.94K-40.69%3.21M-80.03%257.11K-71.13%673.94K69.67%1.22M-1.03%1.06M154.57%5.41M103.07%1.29M473.57%2.33M
Operating profit 46.52%-2.75M38.45%-2.83M-10.82%-14.42M59.32%-1.78M14.51%-2.9M-173.43%-5.15M-36.33%-4.59M-68.90%-13.01M-145.76%-4.37M-60.57%-3.4M
Net non-operating interest income expense 81.53%-58-109.37%-101100.11%45799.80%-9899.70%-21099.78%-314100.64%1.08K47.95%-427.54K75.71%-49.72K69.24%-69.35K
Non-operating interest income ----------457---98----------1.08K------------
Non-operating interest expense ------101---------99.70%210---------47.95%427.54K-75.71%49.72K-69.24%69.35K
Total other finance cost -81.53%58-----------------99.78%314----------------
Other net income (expense) -15,276.16%-93.33M-6,422.63%-12.16M-414,259.20%-81.18M-237.46%-607K-1,627.88%-186.4K-149.59%-228.1K
Gain on sale of security -----------------------------366.11%-607K-1,627.88%-186.4K-192.53%-228.1K
Special income (charges) --0-------93.33M---12.16M--0---81.18M------0--0--0
-Less:Impairment of capital assets --0------11.9M--0--0--11.9M------0--0--0
-Write off --0------81.44M--12.16M--0--69.28M------0--0--0
Income before tax 96.81%-2.75M38.43%-2.83M-667.06%-107.75M-202.78%-13.93M21.39%-2.9M-4,207.19%-86.33M-22.48%-4.59M-73.77%-14.05M-133.72%-4.6M-96.43%-3.69M
Income tax 100.12%9.71K0-9.46M-596.07K-485-7.81M-1.05M000
Net income 96.48%-2.76M20.24%-2.83M-599.75%-98.3M-189.82%-13.34M21.40%-2.9M-3,817.40%-78.51M5.46%-3.54M-73.77%-14.05M-133.72%-4.6M-96.43%-3.69M
Net income continuous Operations 96.48%-2.76M20.24%-2.83M-599.75%-98.3M-189.82%-13.34M21.40%-2.9M-3,817.40%-78.51M5.46%-3.54M-73.77%-14.05M-133.72%-4.6M-96.43%-3.69M
Minority interest income
Net income attributable to the parent company 96.48%-2.76M20.24%-2.83M-599.75%-98.3M-189.82%-13.34M21.40%-2.9M-3,817.40%-78.51M5.46%-3.54M-73.77%-14.05M-133.72%-4.6M-96.43%-3.69M
Preferred stock dividends -20.64%7.95M0-99.67%32.37K2,290.05%7.92M10.02M09.68M
Other preferred stock dividends
Net income attributable to common stockholders 96.80%-2.76M20.24%-2.83M-341.53%-106.25M-189.82%-13.34M78.06%-2.93M-3,600.80%-86.43M5.46%-3.54M-197.66%-24.06M-133.72%-4.6M-611.59%-13.38M
Basic earnings per share 98.05%-33.196.67%-45.3-214.85%-1.09K81.44%-32.917993.89%-31.5-4,740.34%-1.69K-2,408.63%-1.36K-147.42%-346.104-523.36%-177.3656-1,797.86%-515.5409
Diluted earnings per share 98.05%-33.196.67%-45.3-214.85%-1.09K81.44%-32.917993.89%-31.5-4,740.34%-1.69K-2,408.63%-1.36K-147.42%-346.104-523.36%-177.3656-1,797.86%-515.5409
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data